Garadacimab (Anti-F12 / Factor XII)

Garadacimab (Anti-F12 / Factor XII) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research. MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2503
Sku # A2503-1mg*5
Pricing 1mg*5, $970.00
Feedback